Fondaparinux: a new synthetic pentasaccharide for thrombosis prevention.
Bounameaux
Henri
H
Division of Angiology and Haemostasis, Department of Internal Medicine and Institute for Social and Preventive Medicine, University Hospitals of Geneva, 1211 Geneva 14, Switzerland. henri.bounameaux@medecine.unige.ch
Perneger
Thomas
T
D019644:Arthroplasty, Replacement, Hip; D002986:Clinical Trials as Topic; D017984:Enoxaparin / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D000077425:Fondaparinux; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D011134:Polysaccharides / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000188:drug therapy*; D020246:Venous Thrombosis / Q000188:drug therapy* / Q000209:etiology
D017984:Enoxaparin; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D011134:Polysaccharides; D000077425:Fondaparinux